Skip to Main Content
Yale Institute for Global Health
Yale Home

INFORMATION FOR

    Diseases of the Cardiovascular System

    Safe and Timely Antithrombotic Removal - Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D)

    What is the purpose of this trial?

    Prospective, Multicenter, Double-blind, Randomized, Study to Evaluate DrugSorb-ATR Removal of Apixaban and Rivaroxaban to Reduce Likelihood of Serious Bleeding in Patients Undergoing Urgent Cardiothoracic Surgery

    • Trial with
      CytoSorbents, Inc.
    • Ages
      18 years and older
    • Gender
      Both
    Find out more about who can participate in this trial

    Contact Information

    For more information about this study, including how to volunteer, contact Ricarda Tomlin

    Help Us Discover!

    You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

    Create a volunteer profile

    Sub-Investigators

    • Last Updated
      01/08/2024
    • Study HIC
      #2000031974

    Contact Information

    For more information about this study, including how to volunteer, contact Ricarda Tomlin